MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$34.45
+1.92 (+5.90%)
Performance
1D
+0.76%
1W
+13.43%
1M
+33.11%
3M
+26.28%
6M
+34.99%
1Y
+20.45%
YTD
-13.38%
Open$32.57
Previous Close$32.53
Day High$35.01
Day Low$32.42
52W High$53.65
52W Low$21.95
Volume—
Avg Volume470.2K
Market Cap1.81B
P/E Ratio—
EPS$-2.51
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$27.79
Above
SMA 200
$31.59
Above
RSI (14)
68
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+172.6% upside
Current
$34.45
$34.45
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 190.13M | 546.10M | 525.77M |
| Net Income | 20.86M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 69.11M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |